Hemoglobin A1c
Hemoglobin A1c is an intervention with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
33.3%
1 of 3 finished
66.7%
2 ended early
1
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Diabetes Electronic Prompt for Improved Care Coordination and Treatment in the ED
Early Investigation of Glucose Monitoring After Gestational Diabetes Pilot
Universal Hemoglobin A1c Versus Risk-based Screening for Early Gestational Diabetes Mellitus (EARLY GDM): A Randomized Controlled Trial
Chronic Kidney Disease and Cardiovascular Disease Risk Assessment
Optimal A1c Control in Post Liver or Combined Liver and Kidney Transplant Recipients Who Have Diabetes Mellitus
Clinical Trials (5)
Diabetes Electronic Prompt for Improved Care Coordination and Treatment in the ED
Early Investigation of Glucose Monitoring After Gestational Diabetes Pilot
Universal Hemoglobin A1c Versus Risk-based Screening for Early Gestational Diabetes Mellitus (EARLY GDM): A Randomized Controlled Trial
Chronic Kidney Disease and Cardiovascular Disease Risk Assessment
Optimal A1c Control in Post Liver or Combined Liver and Kidney Transplant Recipients Who Have Diabetes Mellitus
All 5 trials loaded
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 5